Nasdaq or NYSE related Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of January 2024

Nasdaq or NYSE listed Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of Jan-05-2024. Nasdaq and NYSE related Biotechnology: Pharmaceutical Preparations industry Largest Companies List by Market Cap as of Jan-05-2024

  1. Supernus Pharmaceuticals

    World Rank (Jan-05-2024)
    6,703
    Market Cap (Jan-05-2024)
    1.522 Billion USD
    World Rank (Jul-30-2023)
    6,453
    Market Cap (Jul-30-2023)
    1.657 Billion USD
    World Rank (Dec-25-2022)
    5,403
    Market Cap (Dec-25-2022)
    2.026 Billion USD
    World Rank (Jan-07-2022)
    7,241
    Market Cap (Jan-07-2022)
    1.58 Billion USD
    Annual Revenue in USD
    667 Million USD
    Annual Operating Income in USD
    46 Million USD
    Annual Net Income in USD
    61 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Frankfurt
    Company Profile
    Supernus Pharmaceuticals is a pharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system diseases. The company annual revenue is 392.8 million USD and 464 employees as on 2019. The headquarters is in USA.
    Company Website
    SUPERNUS PHARMACEUTICALS INC

  2. Pacira Biosciences

    World Rank (Jan-05-2024)
    6,744
    Market Cap (Jan-05-2024)
    1.506 Billion USD
    World Rank (Jul-30-2023)
    6,485
    Market Cap (Jul-30-2023)
    1.645 Billion USD
    World Rank (Dec-25-2022)
    5,773
    Market Cap (Dec-25-2022)
    1.820 Billion USD
    World Rank (Jan-07-2022)
    5,267
    Market Cap (Jan-07-2022)
    2.67 Billion USD
    Annual Revenue in USD
    666 Million USD
    Annual Operating Income in USD
    71 Million USD
    Annual Net Income in USD
    16 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Pacira BioSciences is a Pharmaceutical company. It is the organization built on high ethical standards an unwavering commitment to patients and transparent communications and have a drive and a desire to improve the world around and make a meaningful difference in the lives of patients, families, communities and society. The headquarters is in USA.
    Company Website
    PACIRA BIOSCIENCES

  3. Arcus Biosciences

    World Rank (Jan-05-2024)
    6,836
    Market Cap (Jan-05-2024)
    1.477 Billion USD
    World Rank (Jul-30-2023)
    7,002
    Market Cap (Jul-30-2023)
    1.455 Billion USD
    World Rank (Dec-25-2022)
    6,609
    Market Cap (Dec-25-2022)
    1.478 Billion USD
    World Rank (Jan-07-2022)
    5,322
    Market Cap (Jan-07-2022)
    2.63 Billion USD
    Annual Revenue in USD
    112 Million USD
    Annual Operating Income in USD
    -280 Million USD
    Annual Net Income in USD
    -267 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ NYSE
    Company Profile
    Arcus is a Biopharmaceutical company aiming to bring together scientists, physicians and advisors to focus on developing best in class cancer therapies. The company annual revenue is 77.8 million USD and 108 employees as on 2019. The headquarters is in USA.
    Company Website
    ARCUS BIOSCIENCES

  4. Disc Medicine Inc.

    World Rank (Jan-05-2024)
    6,852
    Market Cap (Jan-05-2024)
    1.472 Billion USD
    World Rank (Jul-30-2023)
    8,317
    Market Cap (Jul-30-2023)
    1.089 Billion USD
    Headquarters Country
    USA
    Company Website
    DISC MEDICINE INC.

  5. Keros Therapeutics Inc.

    World Rank (Jan-05-2024)
    6,873
    Market Cap (Jan-05-2024)
    1.464 Billion USD
    World Rank (Jul-30-2023)
    7,679
    Market Cap (Jul-30-2023)
    1.242 Billion USD
    World Rank (Dec-25-2022)
    7,230
    Market Cap (Dec-25-2022)
    1.286 Billion USD
    World Rank (Jan-07-2022)
    8,347
    Market Cap (Jan-07-2022)
    1.24 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -107 Million USD
    Annual Net Income in USD
    -104 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Keros Therapeutics is a Clinical Stage Biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics by leveraging deep understanding of specifically hematopoiesis and musculoskeletal systems. The company annual revenue is 10 million USD and 23 employees as on 2019. The headquarters is in USA.
    Company Website
    KEROS THERAPEUTICS, INC.

  6. Ardelyx

    World Rank (Jan-05-2024)
    6,971
    Market Cap (Jan-05-2024)
    1.428 Billion USD
    World Rank (Jul-30-2023)
    9,735
    Market Cap (Jul-30-2023)
    0.828 Billion USD
    World Rank (Dec-25-2022)
    13,070
    Market Cap (Dec-25-2022)
    0.452 Billion USD
    World Rank (Jan-07-2022)
    22,233
    Market Cap (Jan-07-2022)
    0.11 Billion USD
    Annual Revenue in USD
    52 Million USD
    Annual Operating Income in USD
    -64 Million USD
    Annual Net Income in USD
    -67 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Frankfurt
    Company Profile

    Ardelyx is a Biotechnology company enabled to develop a pipeline of drug candidates designed to better manage complications related to kidney and cardiorenal diseases. The headquarters is in USA.

    Facts About Company

    Ardelyx Annual Total Revenue for year ending Dec-2022 was 52 million USD and and Net loss for year ending Dec-2022 was -67 million USD.

    Ardelyx Annual Total Revenue for year ending Dec-2021 was 10 million USD and and Net loss for year ending Dec-2021 was -158 million USD.

    As on 2022, Ardelyx has 133 employees.

    Company Website
    ARDELYX

  7. Kiniksa Pharmaceuticals

    World Rank (Jan-05-2024)
    7,059
    Market Cap (Jan-05-2024)
    1.405 Billion USD
    World Rank (Jul-30-2023)
    7,387
    Market Cap (Jul-30-2023)
    1.325 Billion USD
    World Rank (Dec-25-2022)
    8,029
    Market Cap (Dec-25-2022)
    1.075 Billion USD
    World Rank (Jan-07-2022)
    10,948
    Market Cap (Jan-07-2022)
    0.76 Billion USD
    Annual Revenue in USD
    38 Million USD
    Annual Net Income in USD
    -157 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Bermuda
    Yahoo @ Nasdaq
    Company Website
    KINIKSA PHARMACEUTICALS

  8. Mirum Pharmaceuticals

    World Rank (Jan-05-2024)
    7,121
    Market Cap (Jan-05-2024)
    1.384 Billion USD
    World Rank (Jul-30-2023)
    8,800
    Market Cap (Jul-30-2023)
    0.988 Billion USD
    World Rank (Dec-25-2022)
    10,559
    Market Cap (Dec-25-2022)
    0.673 Billion USD
    World Rank (Jan-07-2022)
    13,731
    Market Cap (Jan-07-2022)
    0.48 Billion USD
    Annual Revenue in USD
    77 Million USD
    Annual Operating Income in USD
    -131 Million USD
    Annual Net Income in USD
    -135 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Mirum Pharmaceuticals is a Clinical Stage Biopharmaceutical company focused on clinical studies for the treatment of cholestatic diseases including primary sclerosing cholangitis (PSC), intrahepatic cholestasis of pregnancy (ICP) and primary biliary cholangitis (PBC). It is having 24 employees as on 2019. The headquarters is in USA.
    Company Website
    MIRUM PHARMACEUTICALS

  9. Morphic Holding

    World Rank (Jan-05-2024)
    7,160
    Market Cap (Jan-05-2024)
    1.369 Billion USD
    World Rank (Jul-30-2023)
    4,888
    Market Cap (Jul-30-2023)
    2.536 Billion USD
    World Rank (Dec-25-2022)
    8,376
    Market Cap (Dec-25-2022)
    0.995 Billion USD
    World Rank (Jan-07-2022)
    6,756
    Market Cap (Jan-07-2022)
    1.77 Billion USD
    Annual Revenue in USD
    71 Million USD
    Annual Operating Income in USD
    -63 Million USD
    Annual Net Income in USD
    -59 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Frankfurt
    Company Profile
    Morphic Holding is a Biopharmaceutical company leading the development of a new generation of oral integrin drugs and a unique integrin discovery platform. It is having 76 employees as on 2019. The headquarters is in USA.
    Company Website
    MORPHIC HOLDING

  10. Xencor

    World Rank (Jan-05-2024)
    7,236
    Market Cap (Jan-05-2024)
    1.346 Billion USD
    World Rank (Jul-30-2023)
    7,028
    Market Cap (Jul-30-2023)
    1.449 Billion USD
    World Rank (Dec-25-2022)
    6,390
    Market Cap (Dec-25-2022)
    1.564 Billion USD
    World Rank (Jan-07-2022)
    5,875
    Market Cap (Jan-07-2022)
    2.22 Billion USD
    Annual Revenue in USD
    164 Million USD
    Annual Operating Income in USD
    -82 Million USD
    Annual Net Income in USD
    -55 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Xencor is a Clinical Stage Biopharmaceutical company. It has portfolio of 18 proprietary and partnered therapeutic antibody and cytokine programs in clinical development for the treatment of cancer autoimmune disorders and infectious disease. The headquarters is in USA.
    Facts About Company
    As on 2021, Xencor had 254 full-time employees.
    Company Website
    XENCOR INC

Share